Skip to main content

Advertisement

Log in

Our greatest untapped resource: our patients

  • Original Article
  • Published:
Journal of Community Genetics Aims and scope Submit manuscript

Abstract

Healthcare is continually evolving to meet the changing needs of twenty-first century populations whilst striving to keeping pace with medical and technological advancements. Patients and clinicians remain the constants in this evolving environment, sitting at the cutting edge of new evidence and innovation and at the coalface of clinical services which need to address the increasingly challenging health priorities we face as a society. Patients and clinicians, positioned centre stage in this changing world, must adjust their relationships and partnerships to reduce the burden of illness and ensure that multifaceted care needs are all properly addressed. In rare diseases, this relationship between patients and professionals demands a new model of care, in which patients are active, valued partners in their own care and function not as ‘enlightened self-interested’ individuals but as experts by experience. The unique characteristics of rare diseases demand that care evolves beyond multidisciplinary team care to ‘Networked-care’, in which care is prescribed based upon the body of experience and expertise of a community of experts and patients (who are experts by experience). Healthcare models are being redrawn around a new norm of clinical practice based on true patient-clinical partnerships in care. A partnership with patients, when supported by proper investment, is a collaborative relationship that aligns both the medical and clinical perspectives of professionals with a holistic perspective of patients’ life experiences. Such partnerships can (i) ensure that decisions around care and design of services are needs-led, (ii) reduce the fog of uncertainty that surrounds rare diseases, (iii) amplify the success of new discoveries, and (iv) create breakthrough innovations: in these ways, patient-clinical partnerships increase the efficiency and effectiveness of our work and build a more sustainable future for our healthcare services.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. A summary of the EUCERD Joint Action and its achievements can be found in Lynn et al. (2017) and Hedley et al. (2018)

  2. See http://www.rd-action.eu/

  3. See https://www.rare2030.eu/

References

Download references

Funding

The perspectives shared in this article do not originate from any particular project or funding opportunity. EURORDIS was/is a partner in the following projects (which are mentioned in the manuscript)

• Rare 2030 PP-1-2-2018-Rare 2030, co-funded by the European Union Pilot Projects and Preparatory Actions Programme

• RD-ACTION: ‘Data and Policies for Rare diseases’ 677024 which received funding from the European Union’s Third Health Program

• EUCERD Joint Action: Working for Rare Diseases (No. 2011 22 01) which received funding from the European Union’s Second Health Programme

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matt Bolz-Johnson.

Ethics declarations

Ethical approval

This article does not discuss or contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

The authors declare no competing interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Rare Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bolz-Johnson, M., Kenny, T., Le Cam, Y. et al. Our greatest untapped resource: our patients. J Community Genet 12, 241–246 (2021). https://doi.org/10.1007/s12687-021-00524-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12687-021-00524-5

Navigation